CAR-T Cell Therapy & AiArthritis Diseases
Welcome to the AiArthritis CAR-T Cell Therapy Page! Here you will learn from our patient leaders about what CAR-T cell therapy is and what it means for the AiArthritis disease community.
What is CAR-T Cell Therapy? CAR‑T cell therapy (chimeric antigen receptor T‑cell therapy) is an advanced treatment that uses a person’s own immune cells to fight disease, and the way it works has been changing and improving over time. It was first used for certain blood cancers and given only in highly specialized hospitals, but now it is also being studied as a possible option for autoimmune and autoinflammatory arthritis diseases. With CAR‑T, some of your T cells (a type of white blood cell) are taken from your blood, changed in a lab so they can better find and attack harmful cells, and then put back into your body. Newer versions are being designed to be safer, longer‑lasting, and easier to receive—aiming to “reset” the immune system more precisely and, in the future, make treatment more accessible for patients.
Go With Us Video Debriefs on CAR-T Cell Therapy from ACR 2025
Join Tiffany Westrich-Robertson, CEO and Original Founder of AiArthritis and Leila P.L. Valete,
AiArthritis Health Education Manager, for patient-led debriefs breaking down the latest updates on CAR-T therapy in a way that’s easy to understand, patient-focused, and relevant to the
AiArthritis disease community.
CAR T Cell Therapy Breakthroughs in Autoimmune Disease
In this update, Tiffany breaks down the latest research on CAR T cell therapy — a groundbreaking treatment that reprograms your own immune cells to “reset” the system and stop autoimmune attacks.
Could CAR-T Lead to Drug-Free Remission for Autoimmune Diseases?
In this Go With Us! video from EULAR 2025, Leila—AiArthritis’ Health Education Manager—dives into one of the most exciting sessions of the conference: CAR-T cell therapy and its potential to reset the immune system in autoimmune diseases like lupus and systemic sclerosis.
Segment on CAR T Therapy: Science Bringing New Hope for Patients
Join Leila P.L. Valete, Health Education Manager at AiArthritis, as she breaks down key updates from Day 1 of ACR 2025 through the Go With Us! program.
AiArthritis Voices 360 Talkshow Episode 113: What is CAR-T Therapy?
Discover more In this episode of AiArthritis Voices 360, co-hosts Leila P.L. Valete, AiArthritis Health Education Manager, and Tiffany Westrich-Robertson, CEO and Original Founder of AiArthritis, explain what CAR-T is, how it works, and why it matters to our community.
Read about CAR-T Cell Therapy on Our Blog
This page was made achievable thanks to the support from our Go With Us to conferences program. To keep up to date with the latest CAR-T information, sign up for the next Go With Us program!
Thank you our Sponsors!
AiArthritis patient leaders have been attending in person and online sessions, alongside rheumatologists and researchers, to learn more about these new treatments. Materials on this page were made possible through these efforts, which are tied to our "Go With Us!" to Conferences program and AiArthritis Voices 360 Talk Show.
